NYSE:AMPE Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis → The AI Bottleneck No One is Talking About (From The Bull Report) (Ad) Free AMPE Stock Alerts $1.66 +0.03 (+1.84%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$1.60▼$1.6850-Day Range$1.56▼$2.3052-Week Range$1.50▼$8.30Volume33,616 shsAverage Volume188,042 shsMarket Capitalization$1.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Get Ampio Pharmaceuticals alerts: Email Address Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About Ampio Pharmaceuticals Stock (NYSE:AMPE)Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.Read More AMPE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMPE Stock News HeadlinesMarch 12, 2024 | americanbankingnews.comAmpio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.comFebruary 29, 2024 | msn.comAmpio Pharmaceuticals, Ironwood, Incannex among healthcare moversMarch 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.February 15, 2024 | finanznachrichten.deAmpio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling StudiesFebruary 14, 2024 | prnewswire.comAmpio Provides Update on Results from Pre-IND Enabling StudiesJanuary 26, 2024 | msn.comAmpio Pharmaceuticals Announces At-The-Market Stock OfferingDecember 28, 2023 | seekingalpha.comSociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' packDecember 1, 2023 | msn.comWhat's Going On With Ampio Pharmaceuticals Stock?March 19, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.December 1, 2023 | msn.comRedhill Biopharma, Ampio Pharmaceuticals among healthcare moversNovember 30, 2023 | benzinga.comThinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly GroupOctober 5, 2023 | finance.yahoo.comAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201October 4, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference 63 Day 2 on October 5 Register NowSeptember 26, 2023 | finance.yahoo.comAmpio Pharmaceuticals to Present at the Emerging Growth ConferenceSeptember 7, 2023 | thestreet.comAmpio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary EndpointAugust 31, 2023 | seekingalpha.comAmpio Pharmaceuticals announces 20-to-1 reverse stock splitAugust 31, 2023 | markets.businessinsider.comAmpio Pharmaceuticals Board Approves Reverse Stock Split - Quick FactsAugust 31, 2023 | finance.yahoo.comAmpio Pharmaceuticals Announces Reverse Stock SplitAugust 3, 2023 | benzinga.comThinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?June 22, 2023 | msn.com3 Biotech Stocks to Buy With Explosive Upside PotentialJune 3, 2023 | finance.yahoo.comAMPE - Ampio Pharmaceuticals, Inc.May 26, 2023 | finance.yahoo.comAmpio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockApril 18, 2023 | seekingalpha.comAmpio stock jumps ~20% after CEO letter on drug program, reorganizationApril 3, 2023 | thestreet.comAmpio Too Busy to Tell Investors Results of Eye Drug StudyFebruary 9, 2023 | thestreet.comWhy Ampio Pharmaceuticals (AMPE) Stock Is Plummeting TodayFebruary 7, 2023 | wsj.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.December 27, 2022 | finance.yahoo.comAmpio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsSee More Headlines Receive AMPE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today3/18/2024Next Earnings (Estimated)3/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:AMPE CUSIPN/A CIK1411906 Webampiopharma.com Phone720-437-6500Fax720-437-6501Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($12.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-111.36% Return on Assets-85.59% Debt Debt-to-Equity RatioN/A Current Ratio3.37 Quick Ratio3.37 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$15.62 per share Price / Book0.11Miscellaneous Outstanding Shares830,000Free Float805,000Market Cap$1.39 million OptionableNo Data Beta2.00 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Michael A. Martino (Age 67)CEO & Director Comp: $548.14kDr. David Bar-Or M.D. (Age 75)Founder & Chairman of Scientific Advisory Board Comp: $145.6kMr. Daniel G. Stokely CPA (Age 60)CFO, Corporate Secretary & Treasurer Comp: $346.73kApril RamirezClinical Trial ManagerKey CompetitorsSciSparcNASDAQ:SPRCPaxMedicaNASDAQ:PXMDSunshine BiopharmaNASDAQ:SBFM180 Life SciencesNASDAQ:ATNFHistogenNASDAQ:HSTOView All CompetitorsInsidersJ Kevin BuchiBought 1,250 shares on 6/8/2023Total: $7,500.00 ($6.00/share)Michael A MartinoBought 3,844 shares on 5/24/2023Total: $22,295.20 ($5.80/share)David R StevensBought 2,500 shares on 5/11/2023Total: $11,000.00 ($4.40/share)View All Insider Transactions AMPE Stock Analysis - Frequently Asked Questions How have AMPE shares performed in 2024? Ampio Pharmaceuticals' stock was trading at $2.05 at the beginning of 2024. Since then, AMPE stock has decreased by 19.0% and is now trading at $1.66. View the best growth stocks for 2024 here. When is Ampio Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 25th 2024. View our AMPE earnings forecast. How were Ampio Pharmaceuticals' earnings last quarter? Ampio Pharmaceuticals, Inc. (NYSE:AMPE) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.40) EPS for the quarter, meeting analysts' consensus estimates of ($0.40). When did Ampio Pharmaceuticals' stock split? Ampio Pharmaceuticals shares reverse split before market open on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Ampio Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL). Who are Ampio Pharmaceuticals' major shareholders? Ampio Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Dan Stokely, David R Stevens, Holli Cherevka, J Kevin Buchi, Michael A Martino and Philip H Coelho. View institutional ownership trends. How do I buy shares of Ampio Pharmaceuticals? Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AMPE) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.